Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Small cap life sciences business working to address healthcare issue
Thursday 02 Feb 2017 Author: Lisa-Marie Janes

Obesity is becoming an increasingly big issue for governments and businesses.

In Europe, 15.9% of people over the age of 18 are classified as obese.

Scotland is considering enforcing parking restrictions to get people to walk more, while France recently banned unlimited fizzy drinks in restaurants.

Life sciences business Optibiotix (OPTI:AIM) aims to capitalise on our over-indulgence by developing ‘healthy’ sugars that cannot be digested in the human gut, making them calorie-free.

It is working with food, wellbeing and pharmaceutical companies to bring its platforms to market.

‹ Previous2017-02-02Next ›